EP1968549
Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
:
EP einkaleyfi: Þýðing ekki lögð inn:
20.12.2006:
14.5.2014:
06841059.6
:
19.12.2026
:
Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
20.12.2006
14.5.2014
:
Novartis AG:
Lichtstrasse 35, 4056, Basel, CH
:
PETERSEN, Holger:
Eimeldingen, DE
:
AHLHEIM, Markus:
Staufen, DE
:
0526247:
22.12.2005:
GB
:
06119086:
17.8.2006:
EP
:
WO2007071395:
20.12.2006
:
A61K 9/16, A61K 38/31